Research

Construction work is currently underway on a new artificial intelligence research laboratory designed by PLP Architecture. Located in Shanghai, China, the building's overall form is inspired by a computer motherboard and CPU.

From the first published data out of large clinical trials testing MDMA and psilocybin, to some incredible work investigating what psychedelics actually do to a mammalian brain, here are the highlights from a truly landmark year in psychedelic science.

The US National Institutes of Health is investing $470 million dollars into research on long COVID. The massive nationwide study into this often-debilitating condition will include tens of thousands of patients and span more than 30 research institutions.

Do beards to protect our faces from punches? Does corruption in a given country correlate with how obese its politicians are? And why are scientists hanging rhinos off helicopters upside-down? These are a few of this year's Ig Nobel Prize winners.

A new study in the journal Science Advances presents the latest research demonstrating the potential effectiveness of an inhalable COVID-19 vaccine. The vaccine is one of several in development designed to be administered through a nasal spray.

How much of a problem is it if participants in psychedelic clinical trials can easily tell they have been given a placebo? Researcher Suresh Muthukumaraswamy suggests it is, and many findings from recent psychedelic trials may be over-estimated.

Lockdowns, lab closures, funding cuts, and delays to ongoing clinical trials have all contributed to cancer research disruptions that may set the field back two years, according to new estimates made by the Institute of Cancer Research in London.

Eye tracking cameras and AI analysis can reveal your identity, gender, age, ethnicity, weight, personality traits, drug habits, emotions, skills, abilities, fears, interests, and sexual preferences, says a rather dystopian research review.

Several authors behind a paper finding hydroxychloroquine ineffective as a COVID-19 treatment have requested it be retracted. Meanwhile, the first results from a clinical trial testing the drug found it's no better than placebo at preventing COVID-19.

A new research building designed to keep scientists safe in some of the most challenging conditions on the planet has begun construction in Antarctica. The project is defined by its aerodynamic design and is due to be completed in 2023.

The Research app allows health data to be shared with approved medical researchers in the course of conducting different scientific studies.

Researchers have developed a transgenic mouse model with human brain immune cells. The breakthrough will let scientists observe how human brain cells respond to different Alzheimer’s-inducing toxic proteins, advancing our understanding into how neurodegenerative disease progresses.